Search Results - "RINTALA, E."

IL-6 and other biomarkers as predictors of severity in COVID-19 by Broman, N., Rantasärkkä, K., Feuth, T., Valtonen, M., Waris, M., Hohenthal, U., Rintala, E., Karlsson, A., Marttila, H., Peltola, V., Vuorinen, T., Oksi, J.

“…Cytokine release syndrome is suggested to be the most important mechanism triggering acute respiratory distress syndrome and end organ damage in COVID-19. The…”
Get full text

Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study by Uusitalo-Seppälä, R., Huttunen, R., Tarkka, M., Aittoniemi, J., Koskinen, P., Leino, A., Vahlberg, T., Rintala, E. M.

“…Objectives The soluble form of urokinase‐type plasminogen activator (suPAR) was evaluated as an early prognostic marker of sepsis in patients with suspected…”
Get full text

EAU Guidelines on Diagnosis and Treatment of Upper Urinary Tract Transitional Cell Carcinoma by Oosterlinck, W, Solsona, E, van der Meijden, A.P.M, Sylvester, R, Böhle, A, Rintala, E, Lobel, B

“…Objectives: On behalf of the European Association of Urology (EAU) guidelines for diagnosis, therapy and follow-up of upper urinary tract transitional cell…”
Get full text

The Plasma Level of Proprotein Convertase FURIN in Patients with Suspected Infection in the Emergency Room: A Prospective Cohort Study by Ranta, N., Turpeinen, H., Oksanen, A., Hämäläinen, S., Huttunen, R., Uusitalo‐Seppälä, R., Rintala, E., Aittoniemi, J., Pesu, M.

“…There is an increasing need for novel biomarkers that enable better diagnostic and prognostic stratification of patients with suspected infection. A proprotein…”
Get full text

Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy by Savikko, Johanna, Rintala, Jukka M., Rintala, Sini E., Koskinen, Petri K., von Willebrand, Eva

“…Background. Chronic allograft nephropathy (CAN), now defined as interstitial fibrosis and tubular atrophy not otherwise specified, is a near universal finding…”
Get full text

Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients by RUOTSALAINEN, E., JÄRVINEN, A., KOIVULA, I., KAUMA, H., RINTALA, E., LUMIO, J., KOTILAINEN, P., VAARA, M., NIKOSKELAINEN, J., VALTONEN, V.

“… Objectives.  To study whether levofloxacin, added to standard treatment, could reduce the high mortality and complication rates in Staphylococcus aureus…”
Get full text

FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts by Rintala, Jukka M., Savikko, Johanna, Rintala, Sini E., von Willebrand, Eva

“…Background. Acute rejection is the major risk factor for the development of subsequent chronic allograft nephropathy (CAN), which is the primary reason for…”
Get full text

Self-experienced Physical Workload and Risk of Breast Cancer by Rintala, Pirjo E, Pukkala, Eero, Paakkulainen, Harri T, Vihko, Veikko J

“…Objectives The association between the risk of breast cancer and the physical load of work was studied because physical activity may reduce breast cancer risk…”
Get full text

Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer by HOTAKAINEN, K, BJARTELL, A, SANKILA, A, JÄRVINEN, R, PAJU, A, RINTALA, E, HAGLUND, C, STENMAN, U.-H

“…Tumor-associated trypsin inhibitor (TATI) is a marker of mucinous ovarian carcinoma, but it is also widely expressed in other malignant tumors and normal human…”
Get full text

POS-02.21: Upstaging in T1G3 urothelial urinary bladder cancer – an evaluation of data from Nordic cystectomy trial 1 by Sherif, A, Rintala, E, Mestad, O, Nilsson, S, Malmström, P.U, Duchek, M

Get full text

Vascular Endothelial Growth Factor (VEGF) Ligand and Receptor Induction in Rat Renal Allograft Rejection by Rintala, S.E., Savikko, J., Rintala, J.M., von Willebrand, E.

“…Acute rejection is the single most important risk factor for the subsequent development of chronic allograft nephropathy (CAN), which is still the primary…”
Get full text

Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model by Rintala, Jukka M, Savikko, Johanna, Palin, Niina, Rintala, Sini E, Koskinen, Petri K, von Willebrand, Eva

“…BACKGROUNDExpression of both platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) is increased during the development of chronic…”
Get full text

Late steroid therapy in primary acute lung injury by VARPULA, T, PETTILÄ, V, RINTALA, E, TAKKUNEN, O, VALTONEN, V

“…To investigate the effect of steroid treatment in the late phase of primary acute lung injury (ALI) with special emphasis on pneumococcal pneumonia…”
Get full text

Epidermal Growth Factor Inhibition, a Novel Pathway to Prevent Chronic Allograft Injury by Rintala, Jukka M, Savikko, Johanna, Palin, Niina, Rintala, Sini E, Koskinen, Petri K, von Willebrand, Eva

“…BACKGROUNDChronic allograft injury remains a major problem in clinical kidney transplantation and different growth factors participate in its development…”
Get full text

Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis by Rintala, Jukka M., Savikko, Johanna, Rintala, Sini E., Palin, Niina, Koskinen, Petri K.

“…Background Mesangial proliferative glomerulonephritis is a common glomerular disorder that may lead to end-stage renal disease. Epidermal growth factor (EGF)…”
Get full text

The Effect of Leflunomide Analogue FK778 on Development of Chronic Rat Renal Allograft Rejection and Transforming Growth Factor-BETA Expression by Rintala, J.M., Savikko, J., Rintala, S.E., von Willebrand, E.

“…Chronic allograft nephropathy (CAN) remains the primary reason for late allograft loss in kidney transplantation. Transforming growth factor beta (TGF-β) is a…”
Get full text

Early identification of bacteremia by biochemical markers of systemic inflammation by Rintala, M, Aittoniemi, J, Laine, S, Nevalainen, T.J, Nikoskelainen, J

“…Group II phospholipase A2 (PLA2-II), procalcitonin (PCT) and C-reactive protein (CRP) are useful indicators of the severity of inflammation in various…”
Get full text

The Effect of FK778 on Acute Rat Renal Allograft Rejection and Expression of Platelet-Derived Growth Factor and Transforming Growth Factor-Beta by Rintala, J.M., Savikko, J., Rintala, S.E., von Willebrand, E.

“…Acute rejection is the single most important risk factor for the development of subsequent chronic allograft nephropathy (CAN). Both platelet-derived growth…”
Get full text

Granulocyte colony-stimulating factor therapy and systemic inflammation in critically ill patients by Takala, A, Pettilä, V, Takkunen, O, Rintala, E, Kautiainen, H, Repo, H

“…The effect of the granulocyte colony-stimulating factor filgrastim on systemic inflammation was investigated in a prospective, randomized, placebo-controlled,…”
Get full text

Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer by Rosenblatt, Robert, Sherif, Amir, Rintala, Erkki, Wahlqvist, Rolf, Ullén, Anders, Nilsson, Sten, Malmström, Per-Uno

“…Abstract Background Characterising responders to neoadjuvant chemotherapy (NAC) is important to minimise overtreatment and the unnecessary delay of definitive…”
Get full text